A prior study reported that KYNU was highly upregulated in HER2-enriched and triple-negative breast cancer subtypes and that elevated KYNU levels were associated with increased levels of AA and 3-HAA [43]. Here, ERBB2 is linked to triple-negative breast carcinoma.